These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 18782026)

  • 1. Cytokines in colitis associated cancer: potential drug targets?
    Waldner MJ; Neurath MF
    Inflamm Allergy Drug Targets; 2008 Sep; 7(3):187-94. PubMed ID: 18782026
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Master regulator of intestinal disease: IL-6 in chronic inflammation and cancer development.
    Waldner MJ; Neurath MF
    Semin Immunol; 2014 Feb; 26(1):75-9. PubMed ID: 24447345
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epithelial Nuclear Factor-x03BA;B Activation in Inflammatory Bowel Diseases and Colitis-Associated Carcinogenesis.
    Nagaishi T; Watabe T; Jose N; Tokai A; Fujii T; Matsuoka K; Nagahori M; Ohtsuka K; Watanabe M
    Digestion; 2016; 93(1):40-6. PubMed ID: 26789263
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of colon-infiltrating γδ T cells in chronic inflammatory bowel disease and in colitis-associated cancer.
    Lo Presti E; Mocciaro F; Mitri RD; Corsale AM; Di Simone M; Vieni S; Scibetta N; Unti E; Dieli F; Meraviglia S
    J Leukoc Biol; 2020 Aug; 108(2):749-760. PubMed ID: 32202356
    [TBL] [Abstract][Full Text] [Related]  

  • 5. KFL2 participates in the development of ulcerative colitis through inhibiting inflammation via regulating cytokines.
    Wang ZL; Wang YD; Wang K; Li JA; Li L
    Eur Rev Med Pharmacol Sci; 2018 Aug; 22(15):4941-4948. PubMed ID: 30070340
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aberrant function of myeloid-derived suppressor cells (MDSCs) in experimental colitis and in inflammatory bowel disease (IBD) immune responses.
    Kontaki E; Boumpas DT; Tzardi M; Mouzas IA; Papadakis KA; Verginis P
    Autoimmunity; 2017 May; 50(3):170-181. PubMed ID: 28276713
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Decade of Th9 Cells: Role of Th9 Cells in Inflammatory Bowel Disease.
    Vyas SP; Goswami R
    Front Immunol; 2018; 9():1139. PubMed ID: 29881387
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytokine mRNA expression in intestinal tissue of interleukin-2 deficient mice with bowel inflammation.
    Autenrieth IB; Bucheler N; Bohn E; Heinze G; Horak I
    Gut; 1997 Dec; 41(6):793-800. PubMed ID: 9462212
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential avenues for immunotherapy of colitis-associated neoplasia.
    Waldner MJ; Neurath MF
    Immunotherapy; 2012 Apr; 4(4):397-405. PubMed ID: 22512634
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The oncoprotein gankyrin promotes the development of colitis-associated cancer through activation of STAT3.
    Sakurai T; Higashitsuji H; Kashida H; Watanabe T; Komeda Y; Nagai T; Hagiwara S; Kitano M; Nishida N; Abe T; Kiyonari H; Itoh K; Fujita J; Kudo M
    Oncotarget; 2017 Apr; 8(15):24762-24776. PubMed ID: 28160571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunoregulatory Pathways Involved in Inflammatory Bowel Disease.
    Fonseca-Camarillo G; Yamamoto-Furusho JK
    Inflamm Bowel Dis; 2015 Sep; 21(9):2188-93. PubMed ID: 26111210
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Helicobacter hepaticus-induced colitis in interleukin-10-deficient mice: cytokine requirements for the induction and maintenance of intestinal inflammation.
    Kullberg MC; Rothfuchs AG; Jankovic D; Caspar P; Wynn TA; Gorelick PL; Cheever AW; Sher A
    Infect Immun; 2001 Jul; 69(7):4232-41. PubMed ID: 11401959
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunopathogenesis of Colitis-Associated Cancer in an Animal Model.
    Zhao JL; Xiao CX; Guleng B
    Crit Rev Eukaryot Gene Expr; 2015; 25(3):245-51. PubMed ID: 26558947
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chitosan oligosaccharide as potential therapy of inflammatory bowel disease: therapeutic efficacy and possible mechanisms of action.
    Yousef M; Pichyangkura R; Soodvilai S; Chatsudthipong V; Muanprasat C
    Pharmacol Res; 2012 Jul; 66(1):66-79. PubMed ID: 22475725
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inflammation and colorectal cancer.
    Kraus S; Arber N
    Curr Opin Pharmacol; 2009 Aug; 9(4):405-10. PubMed ID: 19589728
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of mangiferin from Belamcanda chinensis on experimental colitis in rats.
    Szandruk M; Merwid-Ląd A; Szeląg A
    Inflammopharmacology; 2018 Apr; 26(2):571-581. PubMed ID: 28337639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of Inflammation in the Development of Colorectal Cancer.
    Muthusami S; Ramachandran IK; Babu KN; Krishnamoorthy S; Guruswamy A; Queimado L; Chaudhuri G; Ramachandran I
    Endocr Metab Immune Disord Drug Targets; 2021; 21(1):77-90. PubMed ID: 32901590
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytokines: from gut inflammation to colorectal cancer.
    Fantini MC; Pallone F
    Curr Drug Targets; 2008 May; 9(5):375-80. PubMed ID: 18473765
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IL-7 promotes long-term in vitro survival of unique long-lived memory subset generated from mucosal effector memory CD4+ T cells in chronic colitis mice.
    Takahara M; Nemoto Y; Oshima S; Matsuzawa Y; Kanai T; Okamoto R; Tsuchiya K; Nakamura T; Yamamoto K; Watanabe M
    Immunol Lett; 2013; 156(1-2):82-93. PubMed ID: 24070768
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TL1A modulates the severity of colitis by promoting Th9 differentiation and IL-9 secretion.
    Wang D; Li H; Duan YY; Han F; Luo YX; Wu MY; Yang MY; Zhan RR; Song J; Zhang H; Zhang XL
    Life Sci; 2019 Aug; 231():116536. PubMed ID: 31176785
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.